source_name
CD45+ cells
individual
Pt19
disease state
RA
duration ra
0.7 yr
treatment
Placebo (0mL)
treatment dose
Placebo (0mL)
cell type
PBMC
sorted cells
CD45+ immune cells
time
day1 baseline and 28 days post-dosing